Analyst Ratings for Xilio Therapeutics Inc (XLO)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2025 | Leerink | Daina Graybosch | New Coverage | Outperform (N/A) |
2.00 (N/A) |
0.67 (8.88) |
1225.37% | Details |
| 12/21/2022 | Chardan | Matthew Barcus | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.97 (8.88) |
350.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
